Friday, May 27, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



France begins Covid-19 vaccine production

France begins Covid-19 vaccine production

Paris, Apr 7 (Prensa Latina) France begins on Wednesday the production of Covid-19 vaccines at a factory located in the northern department of Eure and Loir, after signing contracts with international labs to neutralize the SARS-CoV-2 coronavirus.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The Delpharm Company will start the production of the Pfizer / BioNTech vaccines, under license from the pharmaceutical companies that put an RNA–based vaccine on the market.

According to French government, Recipharm Company will produce the also RNA-based Covid-19 vaccine from the Moderna laboratory by mid-April.

Pfizer / BioNTech and Moderna vaccines were among the first available on the globe to fight the pandemic responsible in the last year for nearly three million deaths, over 97,000 in France.

Agnès Pannier-Runacher, minister of Industry, told the press that France´s objective is to produce as many as 250 million vaccine doses in the country during the rest of the year.

Industrial production of the first French vaccine candidate, a biological preparation from the Sanofi Company, is expected to be produced in summer.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.